M1 Kliniken AG (XTRA:M12) signed an agreement to acquire 48.16% stake in HAEMATO AG (XTRA:HAE) from MPH Health Care AG (XTRA:93M) for €24.2 million on June 10, 2020. Pursuant to the terms of the agreement, M1 Kliniken AG will acquire around 11.01 million shares in HAEMATO AG by issuing approximately 2.14 million shares through a capital increase, against contribution in kind, excluding the subscription rights of shareholders, using the existing authorised capital. The new shares will be subscribed exclusively by MPH Health Care AG.

Post completion, HAEMATO will continue to operate under its own brand. Zimdars, currently Executive Board Member of HAEMATO AG and Supervisory Board Member of M1 Kliniken AG will leave the executive Board of HAEMATO on June 30, 2020. The deal is expected to close on July 1, 2020.